As of February 2025, Ozempic hasn’t been recalled by the US FDA. However, the FDA has had the medication’s warning label updated a few times to add health risks like gallbladder diseases, ileus, and others. Despite the current wave of glucagon-like peptide (GLP-1) RA lawsuits, the product is still being prescribed to people.
Ozempic is a medication prescribed as treatment for people suffering from type 2 diabetes. It's also been touted as a way to manage weight. Studies have shown, however, that GLP-1 RAs can also cause serious health conditions like gastroparesis, vision loss, and bowel obstruction. There are over 1,300 pending lawsuits against GLP-1 RAs, and the number grows.
Despite the seriousness of its health risks, Ozempic is still readily available. If you’re suffering from gastroparesis, vision loss, or bowel obstruction after at least one round of semaglutide treatment, you may be entitled to a claim. Prepare your Ozempic prescription records and medical records showing your diagnosis of a linkable medical condition if you want to find out about your eligibility.